FDA Established Pharmacologic Class · N0000175414
Anthracycline Topoisomerase Inhibitor
Pharmacological class containing 4 drugs per the FDA Established Pharmacologic Class taxonomy.
Drugs in this class (4)
Need clinical context — common uses, side effects, or interactions for this class?
Ask GoDavaii AI about Anthracycline Topoisomerase InhibitorCommon questions about Anthracycline Topoisomerase Inhibitor
What is the Anthracycline Topoisomerase Inhibitor drug class?
Anthracycline Topoisomerase Inhibitor is a pharmacological class in the FDA Established Pharmacologic Class taxonomy, classification code N0000175414. It groups 4 drugs that share a similar mechanism of action, chemical structure, or therapeutic use.
Which drugs are part of the Anthracycline Topoisomerase Inhibitor class?
Notable drugs in the Anthracycline Topoisomerase Inhibitor class include daunorubicin, doxorubicin, epirubicin, idarubicin. The complete member list is shown above on this page; tap any drug name to see its full Indian-context information sheet.
What does FDA Established Pharmacologic Class mean?
FDA Established Pharmacologic Class is one of the standard taxonomies used by the NIH National Library of Medicine to organise drugs. Different taxonomies group drugs by different criteria - some by chemical structure, some by what they do in the body, some by therapeutic intent. Together these classifications make medical research, prescribing and education more consistent across the world.
Where can I get plain-language clinical context for the Anthracycline Topoisomerase Inhibitor class?
For plain-language clinical context - common uses, side effects, drug interactions and what the class means for an Indian patient - ask GoDavaii's Health AI. It works in 22+ Indian languages, is free and needs no signup. Tap "Ask GoDavaii AI about Anthracycline Topoisomerase Inhibitor" above.
Source: NIH RxClass — National Library of Medicine, public domain. Class taxonomy: FDA Established Pharmacologic Class. View on RxClass ↗